Daksh Thaper
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 15, 2024
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Journal: Nature communications
Published: September 30, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.
Journal: Nature cell biology
Published: January 29, 2021
Neural Transcription Factors in Disease Progression.
Journal: Advances in experimental medicine and biology
Published: January 05, 2020
PEG10 is associated with treatment-induced neuroendocrine prostate cancer.
Journal: Journal of molecular endocrinology
Published: March 13, 2019
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
Journal: EMBO molecular medicine
Published: January 20, 2018
Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer.
Journal: Recent patents on anti-cancer drug discovery
Published: October 06, 2016
Targeting Lyn regulates Snail family shuttling and inhibits metastasis.
Journal: Oncogene
Published: July 18, 2016
Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
Journal: Scientific reports
Published: April 26, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
Journal: Cancer discovery
Published: October 22, 2015
Last Updated: 09/26/2026